FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells

Cellular Signalling

Volumn 27, Issue 3, 2015, Pages 510-518

  Liu, Hao ^a   Yin, Jiang ^a   Wang, Hongsheng ^b   Jiang, Guanmin ^c   Deng, Min ^a   Zhang, Ge ^b   Bu, Xianzhang ^b   Cai, Shaohui ^d   Du, Jun ^b   He, Zhimin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition; FOXO3a; MiR 34b c; Prostate cancer; catenin

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 34B; MICRORNA 34C; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; WNT PROTEIN; 3' UNTRANSLATED REGION; ANTISENSE OLIGONUCLEOTIDE; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; MIRN34 MICRORNA, HUMAN; PROTEIN BINDING; SMALL INTERFERING RNA; T CELL FACTOR PROTEIN;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSACTIVATION; 3' UNTRANSLATED REGION; ANTAGONISTS AND INHIBITORS; CELL MOTION; DOWN REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; RNA INTERFERENCE; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

3' UNTRANSLATED REGIONS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; PROTEIN BINDING; RNA INTERFERENCE; RNA, SMALL INTERFERING; TCF TRANSCRIPTION FACTORS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84922635316     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.01.001     Document Type: Article

References (51)

1. Center M.M., Jemal A., Lortet-Tieulent J., Ward E., Ferlay J., Brawley O., Bray F. Eur. Urol. 2012, 61:1079-1092.
2. Taichman R.S., Loberg R.D., Mehra R., Pienta K.J. J. Clin. Invest. 2007, 117:2351-2361.
3. Matuszak E.A., Kyprianou N. Expert. Rev. Endocrinol. Metab. 2011, 6:469-482.
4. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Cell 2009, 139:871-890.
5. Yilmaz M., Christofori G. Cancer Metastasis Rev. 2009, 28:15-33.
6. Micalizzi D.S., Farabaugh S.M., Ford H.L. J. Mammary Gland Biol. Neoplasia 2010, 15:117-134.
7. Kalluri R., Weinberg R.A. J. Clin. Invest. 2009, 119:1420-1428.
8. Lee T.K., Poon R.T., Yuen A.P., Ling M.T., Kwok W.K., Wang X.H., Wong Y.C., Guan X.Y., Man K., Chau K.L., Fan S.T. Clin. Cancer Res. 2006, 12:5369-5376.
9. Huber M.A., Kraut N., Beug H. Curr. Opin. Cell Biol. 2005, 17:548-558.
10. Logan C.Y., Nusse R. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
11. Jiang Y.G., Luo Y., He D.L., Li X., Zhang L.L., Peng T., Li M.C., Lin Y.H. Int. J. Urol. 2007, 14:1034-1039.
12. Yook J.I., Li X.Y., Ota I., Fearon E.R., Weiss S.J. J. Biol. Chem. 2005, 280:11740-11748.
13. Whitaker H.C., Girling J., Warren A.Y., Leung H., Mills I.G., Neal D.E. Prostate 2008, 68:1196-1205.
14. Fenner A. Nat. Rev. Urol. 2012, 9:124.
15. Carnero A. Curr. Pharm. Des. 2010, 16:34-44.
16. Taylor B.S., Schultz N., Hieronymus H., Gopalan A., Xiao Y., Carver B.S., Arora V.K., Kaushik P., Cerami E., Reva B., Antipin Y., Mitsiades N., Landers T., Dolgalev I., Major J.E., Wilson M., Socci N.D., Lash A.E., Heguy A., Eastham J.A., Scher H.I., Reuter V.E., Scardino P.T., Sander C., Sawyers C.L., Gerald W.L. Cancer Cell 2010, 18:11-22.
17. Bitting R.L., Armstrong A.J. Endocr. Relat. Cancer 2013, 20:R83-R99.
18. Ham W.S., Cho N.H., Kim W.T., Ju H.J., Lee J.S., Choi Y.D. J. Urol. 2009, 182:1378-1384.
19. Yang J.Y., Hung M.C. Clin. Cancer Res. 2009, 15:752-757.
20. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Cell 1999, 96:857-868.
21. Liu H., Zhou B.H., Qiu X., Wang H.S., Zhang F., Fang R., Wang X.F., Cai S.H., Du J., Bu X.Z. Free Radic. Biol. Med. 2012, 53:2204-2217.
22. Sunters A., Fernandez de Mattos S., Stahl M., Brosens J.J., Zoumpoulidou G., Saunders C.A., Coffer P.J., Medema R.H., Coombes R.C., Lam E.W. J. Biol. Chem. 2003, 278:49795-49805.
23. Cornforth A.N., Davis J.S., Khanifar E., Nastiuk K.L., Krolewski J.J. Oncogene 2008, 27:4422-4433.
24. Dijkers P.F., Medema R.H., Pals C., Banerji L., Thomas N.S., Lam E.W., Burgering B.M., Raaijmakers J.A., Lammers J.W., Koenderman L., Coffer P.J. Mol. Cell. Biol. 2000, 20:9138-9148.
25. Furukawa-Hibi Y., Kobayashi Y., Chen C., Motoyama N. Antioxid. Redox Signal. 2005, 7:752-760.
26. Liu H., Yin J., Wang C., Gu Y., Deng M., He Z. Anticancer Drugs 2014, 25:898-907.
27. Yang J.Y., Zong C.S., Xia W., Yamaguchi H., Ding Q., Xie X., Lang J.Y., Lai C.C., Chang C.J., Huang W.C., Huang H., Kuo H.P., Lee D.F., Li L.Y., Lien H.C., Cheng X., Chang K.J., Hsiao C.D., Tsai F.J., Tsai C.H., Sahin A.A., Muller W.J., Mills G.B., Yu D., Hortobagyi G.N., Hung M.C. Nat. Cell Biol. 2008, 10:138-148.
28. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., Kobayashi R., Hung M.C. Cell 2004, 117:225-237.
29. Potente M., Urbich C., Sasaki K., Hofmann W.K., Heeschen C., Aicher A., Kollipara R., DePinho R.A., Zeiher A.M., Dimmeler S. J. Clin. Invest. 2005, 115:2382-2392.
30. Shukla S., Shukla M., Maclennan G.T., Fu P., Gupta S. Int. J. Oncol. 2009, 34:1613-1620.
31. Shukla S., Bhaskaran N., Maclennan G.T., Gupta S. Prostate 2013, 73:1507-1517.
32. Essers M.A., de Vries-Smits L.M., Barker N., Polderman P.E., Burgering B.M., Korswagen H.C. Science 2005, 308:1181-1184.
33. Hoogeboom D., Essers M.A., Polderman P.E., Voets E., Smits L.M., Burgering B.M. J. Biol. Chem. 2008, 283:9224-9230.
34. van der Vos K.E., Coffer P.J. Oncogene 2008, 27:2289-2299.
35. Kim N.H., Kim H.S., Kim N.G., Lee I., Choi H.S., Li X.Y., Kang S.E., Cha S.Y., Ryu J.K., Na J.M., Park C., Kim K., Lee S., Gumbiner B.M., Yook J.I., Weiss S.J. Sci. Signal. 2011, 4:ra71.
36. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S., Chen C., Lowe S.W., Cleary M.A., Hannon G.J. Nature 2007, 447:1130-1134.
37. Grant C.M., Kyprianou N. Transl Androl Urol. 2013, 2:202-211.
38. Tzivion G., Dobson M., Ramakrishnan G. Biochim. Biophys. Acta 2011, 1813:1938-1945.
39. Ali I.U., Schriml L.M., Dean M. J. Natl. Cancer Inst. 1999, 91:1922-1932.
40. Shen M.M., Abate-Shen C. Cancer Res. 2007, 67:6535-6538.
41. Trotman L.C., Alimonti A., Scaglioni P.P., Koutcher J.A., Cordon-Cardo C., Pandolfi P.P. Nature 2006, 441:523-527.
42. Lynch R.L., Konicek B.W., McNulty A.M., Hanna K.R., Lewis J.E., Neubauer B.L., Graff J.R. Mol. Cancer Res. 2005, 3:163-169.
43. Maiese K., Chong Z.Z., Shang Y.C., Hou J. Med. Res. Rev. 2009, 29:395-418.
44. Chesire D.R., Ewing C.M., Gage W.R., Isaacs W.B. Oncogene 2002, 21:2679-2694.
45. Neth P., Ries C., Karow M., Egea V., Ilmer M., Jochum M. Stem Cell Rev. 2007, 3:18-29.
46. Fodde R., Brabletz T. Curr. Opin. Cell Biol. 2007, 19:150-158.
47. Sanchez-Tillo E., de Barrios O., Siles L., Cuatrecasas M., Castells A., Postigo A. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19204-19209.
48. Shiota M., Song Y., Yokomizo A., Kiyoshima K., Tada Y., Uchino H., Uchiumi T., Inokuchi J., Oda Y., Kuroiwa K., Tatsugami K., Naito S. Clin. Cancer Res. 2010, 16:5654-5663.
49. Belguise K., Guo S., Sonenshein G.E. Cancer Res. 2007, 67:5763-5770.
50. Ni D., Ma X., Li H.Z., Gao Y., Li X.T., Zhang Y., Ai Q., Zhang P., Song E.L., Huang Q.B., Fan Y., Zhang X. Clin. Cancer Res. 2014, 20:1779-1790.
51. Storz P., Doppler H., Copland J.A., Simpson K.J., Toker A. Mol. Cell. Biol. 2009, 29:4906-4917.